Table 2. Clinical characteristics of the study subjects.
| Category | UC | CD | HC | P value |
| No. of cases | 22 | 19 | 23 | - |
| Age at enrollment, y | ||||
| Mean±SD | 36.22±10.11 | 34.19±11.76 | 29.71±10.08 | ns |
| Gender, number (%) | ||||
| Female | 5(22.7) | 12(63.2) | 7(30.4) | |
| Disease duration, mo | 41.11±43.51 | 55.64±71.63 | ns | |
| Disease location, n (%) | ||||
| L1 | - | 9(47) | ||
| L2 | - | 7(37) | ||
| L3 | - | 3(16) | ||
| Disease extent, n (%) | ||||
| Proctosigmoiditis | 5(23) | - | ||
| Left-sided colitis | 6(27) | - | ||
| Pancolitis | 11(50) | - | ||
| CRP (mg/L) | 6.05±7.46 | 17.57±18.13 | - | ns |
| ESR (mm/h) | 14.67±11.12 | 30.33±28.52 | - | ns |
| ALB (g/L) | 41.94±3.78 | 38.64±4.45 | - | ns |
| WBC (×109/L) | 6.82±2.72 | 6.09±2.71 | - | ns |
| HGB (g/L) | 128.33±17.96 | 102.52±14.23 | - | ns |
| RBC (×1012/L) | 4.11±0.58 | 3.73±0.76 | - | ns |
| HCT (%) | 35.41±9.96 | 30.69±4.17 | - | ns |
| PLT(×109/L) | 222.71±37.90 | 288.14±109.08 | - | **** |
| FOBT (+), n (%) | 11(50.0) | 7(36.8) | - | - |
UC, ulcerative colitis; CD, Crohn’s disease; HC, healthy control; SD, standard deviation; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ALB, albumin; WBC, white blood cell; HGB, hemoglobin; RBC, red blood cell; HCT, hematocrit; PLT, platelet count; FOBT, fecal occult blood test; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns, not statistically significant.